{"pmid":32369280,"title":"Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.","text":["Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.","N Engl J Med","Bowles, Louise","Platton, Sean","Yartey, Nada","Dave, Minal","Lee, Kurtis","Hart, Daniel P","MacDonald, Vickie","Green, Laura","Sivapalaratnam, Suthesh","Pasi, K John","MacCallum, Peter","32369280"],"journal":"N Engl J Med","authors":["Bowles, Louise","Platton, Sean","Yartey, Nada","Dave, Minal","Lee, Kurtis","Hart, Daniel P","MacDonald, Vickie","Green, Laura","Sivapalaratnam, Suthesh","Pasi, K John","MacCallum, Peter"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369280","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1056/NEJMc2013656","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138496147914752,"score":9.490897,"similar":[{"pmid":32407672,"title":"Coagulation abnormalities and thrombosis in patients with COVID-19.","text":["Coagulation abnormalities and thrombosis in patients with COVID-19.","Lancet Haematol","Levi, Marcel","Thachil, Jecko","Iba, Toshiaki","Levy, Jerrold H","32407672"],"journal":"Lancet Haematol","authors":["Levi, Marcel","Thachil, Jecko","Iba, Toshiaki","Levy, Jerrold H"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407672","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/S2352-3026(20)30145-9","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845372907522,"score":60.80093},{"pmid":32324958,"title":"Lupus anticoagulant is frequent in patients with Covid-19.","text":["Lupus anticoagulant is frequent in patients with Covid-19.","Patients hospitalized for Covid-19 severe infection are more prone to excessive coagulation activation leading to thrombotic events. Tang et al.1 discussed the importance of high D-dimer and Fibrin degradation product level to determine the patient prognostic and the risk of thrombosis. However they did not look at lupus anticoagulant (LAC). Zhang et al. described, three cases of thrombosis associated with antiphospholipid antibodies represented by anticardiolipin (aCL) and anti-beta2-glycoprotein I (abeta2GPI)2. No lupus anticoagulant was detected in any of the patients.","J Thromb Haemost","Harzallah, Ines","Debliquis, Agathe","Drenou, Bernard","32324958"],"abstract":["Patients hospitalized for Covid-19 severe infection are more prone to excessive coagulation activation leading to thrombotic events. Tang et al.1 discussed the importance of high D-dimer and Fibrin degradation product level to determine the patient prognostic and the risk of thrombosis. However they did not look at lupus anticoagulant (LAC). Zhang et al. described, three cases of thrombosis associated with antiphospholipid antibodies represented by anticardiolipin (aCL) and anti-beta2-glycoprotein I (abeta2GPI)2. No lupus anticoagulant was detected in any of the patients."],"journal":"J Thromb Haemost","authors":["Harzallah, Ines","Debliquis, Agathe","Drenou, Bernard"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324958","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jth.14867","topics":["Treatment"],"weight":1,"_version_":1666138493881942016,"score":55.601604},{"pmid":32409176,"title":"COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?","text":["COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?","Rev Neurol (Paris)","Aubignat, M","Godefroy, O","32409176"],"journal":"Rev Neurol (Paris)","authors":["Aubignat, M","Godefroy, O"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409176","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.neurol.2020.05.001","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666897319182729216,"score":52.27966},{"pmid":32470207,"title":"Frequency of lupus anticoagulant in Covid-19 patients.","text":["Frequency of lupus anticoagulant in Covid-19 patients.","We have recently published in the Journal of Thrombosis and Haemostasis the presence of lupus anticoagulant (LAC) at high frequency in Covid-19 patients (Harzallah et al.(1) ). Bowles et al.(2) and Helms et al.(3) have confirmed these results in new publications. Tang(4) has reported discordant data. He has found that very few tested covid-19 patients had positive LAC in a small series (n=12). Bowles et al. have found that LAC were positive in 91% of patients (n=34) with high activated partial thromboplastin time (aPTT).","J Thromb Haemost","Harzallah, Ines","Debliquis, Agathe","Drenou, Bernard","32470207"],"abstract":["We have recently published in the Journal of Thrombosis and Haemostasis the presence of lupus anticoagulant (LAC) at high frequency in Covid-19 patients (Harzallah et al.(1) ). Bowles et al.(2) and Helms et al.(3) have confirmed these results in new publications. Tang(4) has reported discordant data. He has found that very few tested covid-19 patients had positive LAC in a small series (n=12). Bowles et al. have found that LAC were positive in 91% of patients (n=34) with high activated partial thromboplastin time (aPTT)."],"journal":"J Thromb Haemost","authors":["Harzallah, Ines","Debliquis, Agathe","Drenou, Bernard"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470207","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jth.14937","weight":0,"_version_":1668167110002475009,"score":50.03547},{"pmid":32379935,"title":"Response to \"Lupus anticoagulant is frequent in patients with Covid-19\".","text":["Response to \"Lupus anticoagulant is frequent in patients with Covid-19\".","We appreciate the opportunity to respond to the letter from Dr. Ines Harzallah, et al. Antiphospholipid antibody assays including lupus anticoagulant (LAC), anticardiolipin and anti-beta2-glycoprotein I have also been performed in dozens of our patients, however, very few of them got positive results, we don't think that antiphospholipid antibody exists universally in COVID-19 patients. In addition, two of the three reported cases with antiphospholipid antibodies mentioned in the letter [1] also seem to meet the International Society on Haemostasis and Thrombosis (ISTH) criteria of disseminated intravascular coagulation [2], the causality between antiphospholipid antibodies and thrombosis in these cases is still uncertain.","J Thromb Haemost","Tang, Ning","32379935"],"abstract":["We appreciate the opportunity to respond to the letter from Dr. Ines Harzallah, et al. Antiphospholipid antibody assays including lupus anticoagulant (LAC), anticardiolipin and anti-beta2-glycoprotein I have also been performed in dozens of our patients, however, very few of them got positive results, we don't think that antiphospholipid antibody exists universally in COVID-19 patients. In addition, two of the three reported cases with antiphospholipid antibodies mentioned in the letter [1] also seem to meet the International Society on Haemostasis and Thrombosis (ISTH) criteria of disseminated intravascular coagulation [2], the causality between antiphospholipid antibodies and thrombosis in these cases is still uncertain."],"journal":"J Thromb Haemost","authors":["Tang, Ning"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379935","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/jth.14890","weight":0,"_version_":1666262687570460673,"score":47.31844}]}